The structure of coxsackievirus B3

Current Topics in Microbiology and Immunology

Volumn 223, Issue 1, 1997, Pages 191-208

  Muckelbauer, J K ^a   Rossmann, M G ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; VIRUS CAPSID ANTIGEN;

AMINO ACID SEQUENCE; COXSACKIE VIRUS B3; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; VIRUS GENOME;

COXSACKIEVIRUS; MIRIDAE;

EID: 0030800286     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-60687-8_9     Document Type: Review

References (14)

1. Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F (1989) The three-dimensional structure of foot-and-mouth disease virus at 2.9Å resolution. Nature 337:709-716
2. Ansardi DC, Porter DC, Morrow CD (1992) Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles. J Virol 66:4556-4563
3. Badger J, Minor I, Oliveira MA, Smith TJ, Rossmann MG (1989) Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses. Proteins 6:1-19
4. Bergelson JM, Mohanty JG, Crowell RL, St. John N, Lublin DM, Finberg RW (1995) Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol 69:1903-1906
5. Caggana M, Chan P, Ramsingh A (1993) Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J Virol 67:4797-4803
6. Caspar DLD, Klug A (1962) Physical principles in the construction of regular viruses. Cold Springs Harbor Symp Quant Biol 27:1-2
7. Chapman MS, Rossmann MG (1993) Comparison of surface properties of picornaviruses: strategies for hiding the receptor site from immune surveillance. Virology 195:745-756
8. Chelvanayagam G, Heringa J, Argos P (1992) Anatomy and evolution of proteins displaying the viral capsid jellyroll topology. J Mol Biol 228:220-242
9. Chow M, Newman JFE, Filman D, Hogle JM, Rowlands DJ, Brown F (1987) Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature 327:482-486
10. Colonno RJ, Condra JH, Mizutani S, Callahan PL, Davies M, Murcko MA (1988) Evidence for the direct involvement of the rhinovirus canyon in receptor binding. Proc Natl Acad Sci 85:5449-5453
11. Colston E, Racaniello VR (1994) Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor. EMBO J 13:5855-5862
12. Filman DJ, Syed R, Chow M, Macadam AJ, Minor PD, Hogle J (1989) Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. Embo J 8:1567-1579
13. Fox MP, Otto MJ, McKinlay MA (1986) The prevention of rhinovirus and poliovirus uncoating by WIN 51711: a new antiviral drug. Antimicrob Agents Chemother 30:110-116
14. Gauntt CJ, Trousdale MD, LaBadie DRL, Paque RE, Nealon T (1979) Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice. J Med Virol 3:207-220